There was no clear correlation between levels of individual gangliosides and the genetic variant in Gaucher disease [9 samples of severe (neuronopathic), 4 samples of mild (non-neuronopathic) GBA variants, and 8 samples with low ﻿pathogenicity variants which have a higher risk for development of PD]. This evidence concerns the gene GBA1 and Parkinson disease.